Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07675044 · ClinicalTrials.gov registry record
Quantifying the Burden of Type 2 (T2) Inflammation in Asthma
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Not yet
- Registry status
- 200
- Enrollment target
NCT07675044: Clinical Trial study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT07675044 is a clinical trial that has not yet begun recruiting, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07675044 has not yet begun recruiting, sponsored by Icahn School of Medicine at Mount Sinai.
- NOT YET RECRUITING
- Registry status
- 200 participants
- Enrollment target
Study Summary
This study is designed to support the assessment of Type 2 (T2) biomarkers in asthma in primary care and community specialty practices. To assess T2 biomarkers, individuals will be required to complete a breath test for fractional exhaled nitric oxide (FeNO) and consent to a review of their medical records. Asthma often goes undetected in primary care and community settings, and through this study the researchers hope to optimize referral pathways to care.
Primary Outcome
The proportion of patients with FeNO ≥ 25 ppb will be measured by using a hand-held portable machine at a standard flow rate of 50 mL/s. FeNO levels serve as a biomarker for Type 2 airway inflammation.
Interventions
- DIAGNOSTIC_TEST FeNO Breath Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2026-07 |
| Est. Completion | 2027-05 |
What is known before NCT07675044 opens enrollment
NCT07675044 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which FeNO Breath Test is the first listed.
NCT07675044 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07675044 about?
NCT07675044 is a clinical study titled "Quantifying the Burden of Type 2 (T2) Inflammation in Asthma". This study is designed to support the assessment of Type 2 (T2) biomarkers in asthma in primary care and community specialty practices. To assess T2 biomarkers, individuals will be required to complete a breath test for fractional exhaled nitric oxide (FeNO) and consent to a review of their medical ...
What is the current status of trial NCT07675044?
This trial is currently not yet recruiting. The enrollment target is 200 participants. The study started on 2026-07. Estimated completion is 2027-05.
What interventions are being tested in trial NCT07675044?
The interventions under investigation include: FeNO Breath Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07675044?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia